Health Catalyst CEO Simeon Kohl acquires $105,438 in company stock
At a glance
- $HCAT today−0.72%last $1.37
- Vs industry peers−2.04 pts6-peer median +1.31% · far behind
- Since Nov 15−19.9%from the first trade after the story
- 52-week range43.5% above low$0.96 – $3.03
- Last reported profit$40.5Mquarter to Sep 30, 2026 · 10-Q
- In the headline$105,438Amount
Nothing reported about health catalyst across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: $HCAT's deal is more than a number — the real story lies in the details, like financing and regulatory hurdles, which often decide the outcome.
- How the stock is trading: $HCAT -0.72% in the latest session.
- Timing: It came out on a weekend, so the change shown is Friday's and Monday's open is the first chance to trade on it. Market holidays are not detected.
Where the stock stands
Health Catalyst ($HCAT) slipped 0.72% to $1.37 in the latest session. Over the past month it is down 19.9%. It now sits 55% under the 52-week high of $3.03 and 43% above the year's low of $0.96. It has been a volatile year: the high was 3.2 times the low, so moves this size are not unusual for it.
What the filings say
In its latest report (10-Q, filed Nov 5, 2026), $HCAT earned $40.5M over the quarter to Sep 30, 2026 on revenue of $56.3M (-20.2% QoQ). Operations brought in $16.9M of cash over the nine months to Sep 30, 2026; after capital spending, free cash flow was $16.1M. Its most recent filings before this story: 10-Q on Nov 5, 2026, 8-K on Nov 5, 2026, 8-K on Sep 14, 2026. Figures are as filed with the SEC; the $HCAT page has the full statements.
How much coverage it is getting
This is the only story on Health Catalyst in Wook's last 30 days of coverage, so there is no recent run to compare it with.
The bigger picture
Healthcare news is shaped by trials, approvals, and pricing — one decision can shift a drugmaker's fate, while policy changes ripple across the whole sector. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
What to watch next
Check $HCAT's filings for the straight scoop. Compare how different outlets spin the same event to see what's fact and what's flair. Wook AI can help track how far $HCAT has moved from its peak.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on November 15, 2026. $HCAT has moved -19.88% ($1.71 to $1.37). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
